Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 20, 2006

View Archived Issues

Shire makes progress in third quarter

Newly identified H5N1 influenza virus variant spreads

Phase I study reveals safety concerns with XL-999 in cancer patients

tfAAC94 safe in patients with inflammatory arthritis

Study identifies optimal alfimeprase dose for peripheral arterial occlusion

Apadenoson a potential agent for myocardial perfusion imaging

Activity of belimumab evaluated at 76 weeks in SLE patients

Studies detail potential of ruboxistaurin in diabetic cardiomyopathy

SBIR grant will support Alzheimer's diagnostic study of LymPro Test

Synairgen licenses novel peptide for treatment of asthma

GSK and NeuroSearch expand scope of strategic alliance

Improved antitumor efficacy of PEGylated SN38 derivative over SN38 and irinotecan

Intravail technology provides effective oral delivery of antisense drugs in primates

Phase III findings for Aridol to form Q2 2007 NDA filing

Bioheart expands clinical trials of MyoCell adult myogenic stem cell treatment

New phase II trial evaluates PXD-101 in MDS

Introgen licenses new nanotechnology systems

CollaGenex raises funds through sale of common stock

Enrollment completed in pivotal Tocosol Paclitaxel study

Johnson & Johnson to acquire Conor Medsystems

MN-001 begins phase III program in bronchial asthma

NorLevo begins phase I trial in Japan

European orphan drug designation for OAS-PAC-100 in ovarian cancer

Neupro recommended for approval in E.U. for advanced Parkinson's

Emerging companies showcased at BIO-Europe 2006: Palau Pharma

European CHMP recommends approval of Inovelon for Lennox-Gastaut syndrome

Lucentis recommended for approval in E.U. for wet AMD

Negative opinion handed down for Mycograb in E.U.

Exforge recommended for approval in E.U.

Recent Protemix and Dainippon Sumitomo patents describe new antidiabetic agents

New therapeutic agents for schizophrenia, anxiety, etc. disclosed in recent patents

New agents for treating neurological disorders reported in recent patents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...